For Sponsors & Pharma
80%
of clinical trials miss enrollment timelines — and the screening bottleneck is why
At $600K–$8M in lost revenue per day of delay, slow prescreening is one of the most expensive line items in drug development. TrialScreen automates the screening layer and gives you real-time visibility into exactly which sites are pacing to hit targets — and which are not.
Request a Sponsor Demo →The Cost of Delay
Every day of enrollment delay has a price tag
$40K
per day
in lost revenue for every day a trial runs behind schedule
Tufts CSDD
$1,200
per screen failure
in sunk cost when ineligible patients reach a screening visit
Bienkowski et al., JCO 2016
37%
after-hours
of patient interactions happen outside business hours — AI handles them all
Industry benchmark
Sponsor Visibility